Bio-medical beauty group UltraV (CEO Hanjin Kwon) announced on the 25th that three types of "Ultra Vhyal fillers" have obtained product approval from the Thai Ministry of Food and Drug Safety (TFDA) with its technology.

UltraV plans to expand its occupancy factor, of Thailand's medical market by obtaining additional approval from the Ministry of Food and Drug Safety following the product approval of the world's first PDO MICROSPHERE "UltraCol," which was certified for its unrivaled technology in June. Thailand is one of the most sensitive Southeast Asia's representative beauty trends in the Thai market, and it is pointed out that it will force to global advance in Thailand market.

​According to the company, Thailand's medical market currently has a strict screening process by local regulators, which has a high barrier to entry to permits, and only a small number of local brands are officially sold. It plans to actively target Thailand based on the strict and difficult procedures of the Thai Ministry of Food and Drug Safety to obtain permission for this item.

​According to UltraV, "Ultra V hyal filler" was developed to minimize swelling or inflammation that was a problem in existing HA filler products. As a result, a multi-layered filler that provides excellent moldability, optimal point/elasticity, and stable four forces was completed, and a filler using the R-square method that combines hyaluronic acid by controlling high pressure, rotation and rotational energy in vacuum was developed.

​In particular, the R-square method is a patented technology that combines the advantages of two types of hyaluronic acid fillers that increase volume with Monophasic fillers and Biphasic fillers, which are smooth and spread well, and creates a natural volume by minimizing the turn-off phenomenon of existing fillers after the procedure and reducing deformation by external forces, according to the company.

"Ultra V hyal filler" is released in three lines, medium, hard, and fine, depending on the size of the constituent particles, and is manufactured with custom fillers optimized for each part of the face, and its effectiveness and stability are certified by the KFDA, CE, and CFDA.

"We have secured competitiveness in the Thai medical beauty market by acquiring HA filler product approval following the previous "UltraCol" product approval," an UltraV official said. "As Thailand is forming a top five beauty medical market in Asia, we will try to maintain UltraV's unrivaled position in Thailand, a leading beauty and plastic surgery powerhouse in Southeast Asia, with the acquisition of the Food and Drug Administration's approval."

​

​

​